The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
U.S. Acute Care Solutions
![flag not available](https://www.greenhill.com/sites/default/files/n_a_flag.gif)
Advised U.S. Acute Care Solutions, the largest majority physician-owned emergency medicine practice in the United States, on the refinancing of its senior secured notes
![Netherlands Netherlands flag](https://www.greenhill.com/sites/default/files/niederland.gif)
Veen Bosch & Keuning
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advising Veen Bosch & Keuning, the largest book publisher in the Netherlands, on its sale to Simon & Schuster, one of the world’s preeminent publishing houses
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Liontown Resources Limited
![flag not available](https://www.greenhill.com/sites/default/files/n_a_flag.gif)
Advised Australian-based lithium company Liontown Resources Limited on its A$590m debt facility to fund the Kathleen Valley Lithium Project
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
myHomecare Group
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Advising Australian Unity on its acquisition of myHomecare Group
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Audacy Inc.
![flag not available](https://www.greenhill.com/sites/default/files/n_a_flag.gif)
Advising 1L Ad Hoc Group on the pre-packaged restructuring of Audacy, one of the largest multi-platform audio content and entertainment companies with 221 radio stations in 45 distinct markets
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Exit of Homesafe Equity Release Joint Venture
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Adviser to Bendigo and Adelaide Bank on the exit of its investment in the Homesafe Equity Release Joint Venture
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Liontown Resources Limited
![flag not available](https://www.greenhill.com/sites/default/files/n_a_flag.gif)
Advised Australian-based lithium company Liontown Resources Limited on its A$390m equity raising to fund the Kathleen Valley Lithium Project
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Lucky Bucks, LLC
![flag not available](https://www.greenhill.com/sites/default/files/n_a_flag.gif)
Advised the Term Loan Ad Hoc Group to Lucky Bucks, one of the largest Class B coin operated amusement machine (“COAM”) route operators in Georgia, on Lucky Bucks’ financial restructuring and chapter 11 process
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Slayback Pharma LLC
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Azurity Pharmaceuticals, a pharmaceutical company specializing in the provision of innovative medicines to overlooked patients, on the acquisition of Slayback Pharma LLC ("Slayback"), a company focused on complex generic and specialty pharmaceutical products
![France France flag](https://www.greenhill.com/sites/default/files/france.gif)
Central nervous system (CNS) portfolio from Sanofi
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Advising Pharmanovia, a UK based global lifecycle management healthcare company, on the acquisition of a global central nervous system portfolio from Sanofi, the France based innovative global healthcare company
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Liontown Resources Limited
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advising Australian-based lithium company Liontown Resources Limited on its response to change of control proposals from Albemarle Corporation
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Australian Unity Diversified Property Fund
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Advising Australian Unity Property Limited, as the responsible entity of the Australian Unity Diversified Property Fund, on Australian Unity Diversified Property Fund’s merger with Cromwell Direct Property Fund
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Interest in Joint Venture with CarepathRx Health System Solutions
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advising Cigna on its investment in CarepathRx Health System Solutions, under Evernorth, Cigna’s health services subsidiary
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Gaming Services Division of Global Payments
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advising Parthenon Capital, a financial services & technology focused private equity firm, on its acquisition of Global Payment’s Gaming Services Division, a leading provider of on-site and digital payment processing services to companies in the gaming industry, for $415mm
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Clinigen Ltd’s Proleukin
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advising Clinigen Ltd, a UK-based global pharmaceutical services company and portfolio company of Triton Partners, on the sale of Proleukin (Interleukin-2 (Aldesleukin)), to Iovance Biotherapeutics, a late-stage biotechnology company developing novel T cell-based cancer immunotherapies
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Annovera®, Imvexxy®, Bijuva®, and prescription prenatal vitamin products
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Advised TherapeuticsMD, Inc., an innovative, leading women’s healthcare company on definitive agreements to license its products to Mayne Pharma
![Germany Germany flag](https://www.greenhill.com/sites/default/files/germany.gif)
Exyte Management GmbH
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advising Stumpf Capital and Georg Stumpf on the sale of a minority interest in its wholly-owned company, Exyte, a global leader in the design, engineering and delivery of high-tech facilities, to funds affiliated with BDT Capital Partners
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
OZ Minerals Limited
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Advising Australian-based copper company OZ Minerals Limited, on its response to two change of control proposals from BHP Group Limited, the world’s largest diversified resources company
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
GI Alliance
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advising the management and majority physician owners of GI Alliance, the largest gastroenterology practice in the United States, on its recapitalization and buyout of minority partner, Waud Capital
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Liontown Resources
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Liontown Resources, an ASX-listed lithium company focused on the development of the world-class Kathleen Valley Lithium Project, on a lithium spodumene concentrate offtake agreement and A$300m financing facility from Ford Motor Company
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Airtower Networks
![](https://www.greenhill.com/sites/default/files/canada-us-dutch.png)
Advised Airtower Networks on its strategic growth capital raise from DIF Capital Partners
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Syrah Resources
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advisor to Syrah Resources, an ASX-listed industrial minerals and technology company, on its US$107mm loan from the U.S. Department of Energy under the Advanced Technology Vehicles Manufacturing loan program to fund the initial expansion of its Vidalia active anode material facility in Louisiana, USA
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
DGO Gold
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Advising DGO Gold, an ASX-listed gold exploration company, on its recommended, off-market takeover offer from Gold Road Resources, an ASX-listed gold producer
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Theramex
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advising Carlyle, the leading private equity investor, on the acquisition of Theramex, a Women’s health-focused specialty pharmaceutical company . The acquisition was jointly executed with PAI Partners
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Acacia Pharma Group plc
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advising Acacia, a UK-domiciled and Euronext-listed commercial stage biopharmaceutical company, on the sale to Eagle Pharmaceuticals, an integrated pharmaceutical company with R&D, manufacturing and commercial expertise